fda restrictions on compounding bpc-157 MEETING UPDATE! Thursday, the FDA's Pharmacy Advisory Committee voted in support of BPC-157, TB-500, KPV & MOTS-c. #peptide #wellness I am getting so many

Vagus nerve and underlying impact on the gut microbiota-brain axis in behavior and neurodegenerative diseases

While compounds like GLP-1s, BPC-157, MOTS-c, and Cerebrolysin are being studied for pathways involving inflammation, mitochondrial dysfunction, and neuroprotection, there is currently NO peptide proven to stop or reverse Parkinsons disease in humans

A legal compounding route would give some patients access through a doctor and licensed pharmacy

Unfortunately, many people especially those under stress, eating less animal protein, or dealing with digestive issues dont absorb enough B12 from food alone